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Abstract: Background
Studies suggest the anterolateral approach is preferable to the posterior approach
when performing total hip arthroplasty (THA) for displaced intracapsular hip fractures,
due to a perceived reduced risk of reoperations and dislocations. However, this comes
from small studies with short follow-up. We determined whether surgical approach in
THAs performed for hip fracture effects revision-free survival, patient survival, and
intraoperative complications.
Methods
We retrospectively analysed all primary THAs for hip fractures between 2003-2015
recorded in the National Joint Registry for England, Wales, Northern Ireland and the
Isle of Man. The two surgical approach groups (posterior versus anterolateral) were
matched for patient and surgical confounding factors using propensity scores, with
outcomes compared using regression modelling. Outcomes were 5-year revision-free
survival (all-cause, revision for dislocation/subluxation, revision for periprosthetic
fracture), patient survival (30-days, 1-year, and 5-years), and intraoperative
complications.
Results
After matching, 14,536 THAs were studied (7,268 in each group). Five-year cumulative
revision-free survival rates were similar (posterior 97.3% vs. anterolateral 97.4%; sub-
hazard ratio (SHR) 1.15 (95% CI 0.93-1.42)). Five-year revision-free survival rates from
dislocation (SHR=1.28 (CI=0.89-1.84)) and from revision for periprosthetic fracture
(SHR=1.03 (CI=0.68-1.56)) were also comparable. Thirty-day patient survival was
significantly higher with a posterior approach (99.5% vs. 98.8%; hazard ratio
(HR)=0.44 (CI=0.30-0.64)), persisting at 1-year (HR=0.73 (CI=0.64-0.84)) and 5-years
(HR=0.87 (CI=0.81-0.94)). The posterior approach had a lower risk of intraoperative
complications (odds ratio=0.59 (CI=0.45-0.78)).
Conclusions
In THA for hip fractures, the posterior approach had a similar risk of revision, a lower
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
risk of mortality and intraoperative complications compared with the anterolateral
approach. We propose that the posterior approach is as safe as the anterolateral
approach when performing THA for hip fractures, and either approach may be used
according to surgeon preference.
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Studies suggest the anterolateral approach is preferable to the posterior approach when 
performing total hip arthroplasty (THA) for displaced intracapsular hip fractures, due to a 
perceived reduced risk of reoperations and dislocations. However, this comes from small 
studies with short follow-up. We determined whether surgical approach in THAs performed 




We retrospectively analysed all primary THAs for hip fractures between 2003-2015 recorded 
in the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. The 
two surgical approach groups (posterior versus anterolateral) were matched for patient and 
surgical confounding factors using propensity scores, with outcomes compared using 
regression modelling. Outcomes were 5-year revision-free survival (all-cause, revision for 
dislocation/subluxation, revision for periprosthetic fracture), patient survival (30-days, 1-year, 






After matching, 14,536 THAs were studied (7,268 in each group). Five-year cumulative 
revision-free survival rates were similar (posterior 97.3% vs. anterolateral 97.4%; sub-hazard 
ratio (SHR) 1.15 (95% CI 0.93-1.42)). Five-year revision-free survival rates from dislocation 
(SHR=1.28 (CI=0.89-1.84)) and from revision for periprosthetic fracture (SHR=1.03 
(CI=0.68-1.56)) were also comparable. Thirty-day patient survival was significantly higher 
with a posterior approach (99.5% vs. 98.8%; hazard ratio (HR)=0.44 (CI=0.30-0.64)), 
persisting at 1-year (HR=0.73 (CI=0.64-0.84)) and 5-years (HR=0.87 (CI=0.81-0.94)). The 




In THA for hip fractures, the posterior approach had a similar risk of revision, a lower risk of 
mortality and intraoperative complications compared with the anterolateral approach. We 
propose that the posterior approach is as safe as the anterolateral approach when performing 
THA for hip fractures, and either approach may be used according to surgeon preference. 
 
Level of Evidence 








Hip fractures are common in elderly patients (≥60 years), and associated with significant 
mortality, morbidity, and healthcare costs.1, 2 In the US, over 300,000 hip fractures occur 
annually,3 with increasing incidence.4 Displaced intracapsular hip fractures are the 
commonest type (48%),5 and are treated using hemiarthroplasty or total hip arthroplasty 
(THA). THA has lower reoperation rates and improved functional outcomes.6-9 The National 
Institute for Health and Care Excellence recommends that for displaced intracapsular hip 
fractures, THA should be performed in independently mobile patients with no cognitive 
impairment who are medically fit for anaesthesia/surgery.2 However, a recent analysis of the 
UK National Hip Fracture Database (NHFD) involving 114,119 hip fractures reported only 
32% of eligible patients received THA.10 Strategies have now been implemented to improve 
this;2 therefore we expect the number of THAs for hip fractures will increase. 
 
Two main surgical approaches are used for THA, posterior or anterolateral. In the elective 
setting, there is no conclusive evidence to recommend one approach over the other in terms of 
reoperation rates or functional outcomes,11-14 although the posterior approach has been 
associated with lower 90-day mortality.15 Surgeons therefore decide which approach to use, 
largely dictated by training and preference. Few studies have assessed the effect of approach 
on outcomes following THA for hip fracture. Current data suggests the anterolateral 
approach is preferable as it is associated with a reduced risk of reoperations and 
dislocations.16-21 However, these studies were small (171-1,412 THAs) with short-term 
follow-up (3-24 months).  
 
We assessed the effect of surgical approach on outcomes following THA performed for hip 
fractures. 
Methods 
A retrospective analysis of prospectively collected observational data was performed using 
data from the National Joint Registry (NJR) for England, Wales, Northern Ireland and the Isle 
of Man. It was established in April 2003 and is the world’s largest arthroplasty registry.22 
Preoperatively patients consent for their details to be recorded within the NJR and data 
linkage to be performed, with 92% providing consent.22 In the emergency setting, such as 
hip fracture, consent is taken whilst the patient rehabilitates in hospital. Operating teams 
complete data capture forms after performing primary or revision arthroplasty, which are 
entered onto the database. 
 
Independent validation studies have reported data completion and accuracy are excellent for 
primary and revision procedures within the NJR.23, 24 Unique patient identifiers permit 
linkage of primary and revision procedures where components are removed, added or 
exchanged. The NJR achieves high levels of procedure linkage (94%).22 The NJR database 
was linked to the Office for National Statistics (ONS) database (records all-cause mortality). 
 
We used anonymized patient data from the NJR for stemmed primary THAs performed for 
hip fractures between 1st April 2003 and 31st December 2015 (n=18,887; Table 1), which 
allowed at least 1-year of follow-up. The exposure was the surgical approach for THA, 
namely posterior or anterolateral (anterolateral, lateral, and Hardinge). For each procedure the 
NJR collects data on patient demographics and the surgery performed. Data collected 
includes age, sex, body mass index (BMI), date of surgery, American Society of 
Anesthesiologists (ASA) grade, anesthetic, surgeon grade, and components implanted 
(fixation, bearing surface, femoral head size). 
 
Outcomes of interest were revision-free survival (at 5-years), patient survival (at 30-days, 1-
year and 5-years), and intraoperative complications (calcar crack, pelvic and/or femoral shaft 
penetration, trochanteric and/or femoral shaft fracture, and other complications). Revision-
free survival was examined using three survival endpoints: free from all-cause revision (i.e. 
no THA component added, removed and/or exchanged), free from revision for 
dislocation/subluxation, and free from revision for periprosthetic fracture. 
 
Statistical analysis 
We controlled for potential patient and surgical confounding factors using propensity score 
matching. Posterior approach THAs were matched by propensity scores to anterolateral 
approach THAs (one-to-one ratio).25, 26 We matched on the logit of the propensity score with 
a 0.02 standard deviation caliper width. Greedy matching (match to nearest neighbor) without 
replacement was used (each hip matched only once), which has demonstrated superior 
performance for estimating treatment effects.25  
 
Approach groups were matched for age, sex, year of surgery, bilateral THA for hip fracture, 
ASA grade, anesthetic, surgeon grade, THA fixation, bearing surface, and femoral head size. 
Groups were not matched on body mass index because of missing data (81% missing as 
difficult to measure in fracture patients).27 Missing BMI data is a limitation of NJR based 
studies with previous work showing no effect on outcomes following imputation.15, 28, 29 
 
Propensity scores were generated using logistic regression, with scores representing the 
probability (from zero to one) that a posterior approach was used. The two groups were 
matched based on individual propensity scores. The standardised mean difference (SMD) was 
used to measure covariate imbalance before and after matching.30, 31 An SMD of 0.10 or more 
for any covariate following matching was suggestive of residual covariate imbalance.25, 30 
 
Cumulative revision-free and patient survival rates were determined using Kaplan-Meier 
estimates. Patients who were alive with a THA not requiring revision were censored on the 
study end date (31st December 2016). Revision-free survival rates were compared between 
approach groups using Fine and Gray competing risk regression modelling, which accounted 
for mortality risk. Patient survival rates were compared between the groups using Cox 
regression, whilst the risk of intraoperative complications was compared using logistic 
regression. Proportional sub-hazards and hazards assumptions were assessed and satisfied for 
all analyses. To account for clustering within the matched cohort, a robust variance estimator 
was used in the revision-free and patient survival regression models, with a conditional 
logistic regression model used for assessing intraoperative complications.32 Univariable 
regression models were assessed in the matched cohort. As a sensitivity analysis, univariable 
regression models were also assessed in the original unmatched cohort. P-values of  <0.05 
were considered significant, with 95% confidence intervals (CI) also used.  
 
Source of funding 
National Institute for Health Research Bristol Biomedical Research Centre, University 
Hospitals Bristol NHS Foundation Trust and University of Bristol. 
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Results 
In the unmatched cohort (n=18,887; Table 1) six covariates had imbalance between groups 
(SMDs>0.10). After matching there were 14,536 cases available for analysis (7,268 per 
group), with no covariate imbalance suggesting good matching performance (Table 1). All 
analyses are based on the matched cohort unless stated. The mean follow-up period for 
surviving patients not undergoing revision was 4.0-years (range 1.0-13.0), and similar 
between groups (mean 3.9-years posterior and 4.0-years anterolateral). 
 
Revision-free survival 
Overall 350 THAs were revised at a mean postoperative time of 1.8 years (range 0 days to 
12.1 years). The commonest reasons for revision were dislocation/subluxation (n=118; 33.7% 
of all revisions), periprosthetic fracture (n=84; 24.0%), aseptic loosening (n=55; 15.7%), and 
infection (n=53; 15.1%) (Table 2). 
 
The 5-year cumulative revision-free survival rates were similar between the approach groups 
(posterior 97.3% vs. anterolateral 97.4%; sub-hazard ratio (SHR) 1.15 (CI 0.93-1.42); 
p=0.185) (Table 3 and Figure 1). The 5-year cumulative revision-free survival rates for 
dislocation were similar (98.9% vs. 99.2%; SHR 1.28 (CI 0.89-1.84); p=0.188). The 5-year 
cumulative revision-free survival rates for periprosthetic fracture were similar (99.4% vs. 
99.4%; SHR 1.03 (CI 0.68-1.56); p=0.879). 
 
Patient survival 
Overall there were 2,885 deaths at a mean of 2.8 years (range 0 days to 12.2 years) from 
surgery. Thirty-day cumulative patient survival rates were significantly higher in THAs 
implanted using a posterior approach (99.5% vs. 98.8%; hazard ratio (HR)=0.44 (CI=0.30-
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0.64); p<0.001) (Table 3). These observations persisted at 1-year (HR=0.73 (CI=0.64-0.84); 
p<0.001) and 5-years (HR=0.87 (CI=0.81-0.94); p<0.001) (Table 3 and Figure 2). 
 
Intraoperative complications 
Overall the risk of intraoperative complications was 1.5% (n=224). The commonest 
complications were fractures of the calcar (n=80; 36% of all intraoperative complications), 
trochanter (n=61; 27%) and pelvis (n=48; 21%). The risk of intraoperative complications 
with the posterior approach was 1.2% (n=84) compared with 1.9% (n=140) with the 
anterolateral approach. The posterior approach had a significantly lower risk of 
intraoperative complications (odds ratio=0.59 (CI=0.45-0.78); p<0.001). 
 
Sensitivity analyses 
In the unmatched cohort, the same findings were observed as in the matched cohort for 
revision-free survival rates, 30-day patient survival rates, and the risk of intraoperative 
complications (Appendix). However in the unmatched cohort, patient survival rates were 







This is the largest study assessing the influence of surgical approach on outcomes following 
THA for hip fracture. We observed that the posterior approach was associated with a reduced 
risk of mortality and intraoperative complications compared with the anterolateral approach. 
The posterior approach did not confer any increased risk of revision surgery, including 
specifically for dislocation and periprosthetic fracture. 
 
Our observations regarding similar revision rates between the two approach groups were seen 
in both the matched and unmatched cohorts. These findings were contrary to previous studies, 
which have suggested the anterolateral approach is associated with a reduced risk of 
reoperations and dislocations.16-21 Some of these differences may relate to study design. 
Previous studies have been small (most with less than 1,000 THAs) with short-term follow-
up and few outcome events. These previous analyses may have been underpowered for the 
outcomes assessed. Furthermore, previous studies have not matched the two approach groups 
for known risk factors for dislocation and fracture, such as age, sex, implant fixation and 
femoral head size.33, 34 For example in the unmatched cohort, larger femoral head sizes 
(above 36mm) were more commonly used in the posterior compared with the 
anterolateral approach (Table 1: 26.4% vs. 16.6%), which may reduce the risk of 
revision for dislocation. However after matching, the use of large heads were similar 
between groups (posterior 19.0% vs. anterolateral 18.5%). Therefore the current matched 
analysis reduced the risk of confounding, which improves the validity of our findings in a 
large population based study. 
 
The posterior approach is the most commonly used approach when elective THAs are 
performed for arthritis.22, 35 The present unmatched cohort from the NJR also demonstrates 
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that it is the most frequently used approach for THAs performed for hip fracture in this 
setting (56.4%). It has been suggested that surgeons will achieve the best results following 
THAs for hip fracture if they use the approach with which they are most familiar.36 Early 
observations from the NJR of 1,302 THAs performed for hip fracture found a higher revision 
rate with the posterior approach (3.5% vs. 1.3% at 3 years), which coincides with a time 
when the posterior approach was used less frequently for elective THA.20 The increased use 
of the posterior approach for THA may also explain the reduced risk (41%) of intraoperative 
complications, namely fractures, observed. 
 
Hip fracture surgery is associated with high mortality rates, which are much higher than 
elective THA.37 The NHFD reported overall 30-day mortality rates in all hip fractures of 
6.7%, with a secular decline.2 We observed a much lower 30-day mortality rate for all THAs 
for hip fractures (0.9%), reflecting selection bias of medically fit and independently mobile 
patients for THA. Despite this low mortality rate, we still observed a significantly reduced 
risk (56%) of 30-day mortality when using the posterior compared with the anterolateral 
approach. In the matched cohort, this improved patient survivorship waned with time, but had 
not completely dissipated by 5-years postoperatively. Our analysis in the unmatched cohort 
confirmed a significantly reduced risk of 30-day mortality with the posterior approach; 
therefore supporting a real effect of surgical approach on mortality at least in the short-term. 
We are unaware of any other large studies assessing the effect of surgical approach on 
mortality following THA for hip fracture. A study of 409,096 elective THAs from the NJR 
demonstrated a significantly lower 90-day mortality rate in procedures performed using a 
posterior approach.15 These observations parallel the current observations in hip fracture 
patients. The posterior approach is a more muscle sparing approach compared with the 
anterolateral approach and associated with less bleeding.38 Problems therefore seen more 
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commonly following the anterolateral approach include nerve injury,38 reduced muscle 
strength,39 and limping.12 These problems invariably influence patient mobility, especially in 
the early postoperative phase when the mortality risk will be high. Our previous exploration 
of mortality in elective THA demonstrated lower all-cause and respiratory mortality 
with the posterior approach, most likely related to improved mobility, an effect likely to 
be more marked in a frail population.40 We therefore suspect these factors explain the 
lower mortality rates observed, especially in the short-term, when using the posterior 
approach. 
 
Study strengths include using linked data from the world’s largest arthroplasty registry. 
Assessment of an unselected nationwide population reduces the risk of sampling bias, 
improving validity and generalisability. Although randomised controlled trials would be 
ideal for assessing this research question, such trials would be impractical as huge patient 
numbers would be required to power the study given the prevalence of revision, mortality, 
and intraoperative complications were relatively low.41 Therefore large cohort studies ensure 
adequate statistical power and reduce the risk of overfitting the regression models; thus this 
design is ideal for our proposed research question. Robust statistical methods were used in 
this study. This included studying a large matched comparison group, thus reducing any 
effects from other potential confounding factors.27 Finally, studies validating NJR data have 
observed that, when procedures were captured within the NJR, the data completion and 
accuracy were excellent.23, 24 
 
Recognised limitations include using observational data, so causality cannot be inferred. 
THA revision rates can be underestimated in the NJR,23, 24 although there is no reason to 
suspect any underreporting would differ between the approach groups. The NJR does not 
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collect data on patient reported outcome measures (PROMs) following hip fracture, non-
revision procedures (i.e. wound washouts, fixation of fractures, and closed reductions of 
dislocated hips), or complications not requiring further surgery (i.e. conservatively 
treated dislocations, fractures, and infections), which are all important to consider when 
comparing approaches. Therefore we cannot estimate the true incidence of dislocation, 
periprosthetic fracture, and infection after THA for hip fracture, only those undergoing 
revision. Linkage has been possible for NJR and PROMs data for elective THA, which has 
favoured the posterior approach.42  
 
Despite matching there is potential for residual confounding. We could only match for 
covariates where data is collected and available in the NJR, so it is not possible to have 
matched for specific serious medical comorbidities (e.g. renal or cardiac failure), or 
conditions where patients may be at increased risk of THA dislocation (e.g. Parkinson’s 
disease or cerebral palsy), which may have influenced approach selection and the 
findings. However when significant findings were identified, the observed effect sizes were 
large; therefore it is unlikely any unmeasured factors would have been large enough to 
change the direction of the effect sizes. Matching may have also reduced the generalisability 
of the study findings, although similar findings were observed when the analyses were 
repeated in the original unmatched cohort. In addition, our findings may not apply in 
countries using different techniques. For example about 70% of femoral stems were 
cemented in this study. Given cemented stems have a lower risk of fracture compared 
with cementless stems, our findings may not apply in regions performing predominantly 
cementless stem THA for hip fracture.  
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Although the follow-up period was short (mean 4 years), the majority of complications 
attributable to surgical approach would be expected to occur in this period. Matching for BMI 
would have strengthened the findings, but due to low data completion for this variable in hip 
fractures, matching could not be undertaken. Reassuringly the available BMI data was 
similar between the two approach groups before and after matching. The NJR does not 
collect data on the specific details of how each approach was performed. Therefore we 
are limited by not having data on parameters, which may influence the outcomes and 
study findings when considering surgical approach. These include what specific 
approach techniques were used (i.e. anterolateral approach has many variants), the 
repair performed (none, capsular, short external rotators, abductors, and whether 
repairs were soft-tissue or intraosseous), intraoperative blood loss, and surgical time. 
Furthermore it was not possible to explore the effect of the increasingly popular direct 
anterior approach in this study given low numbers and variable collection over the life 
of the NJR. 
 
Conclusions 
This large nationwide study observed that in patients undergoing THA for hip fracture, the 
posterior approach had a similar risk of revision surgery, a lower risk of mortality and 
intraoperative complications compared with the anterolateral approach. We therefore propose 
that the posterior approach is as safe as the anterolateral approach when performing THA for 
hip fractures, and either approach may be used according to surgeon preference.
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Figure 1 Cumulative revision-free survival rate free from all-causes following primary total 
hip arthroplasty (THA) performed for hip fracture by surgical approach. 




Figure 2 Cumulative patient survival rate following primary total hip arthroplasty (THA) 
performed for hip fracture by surgical approach. 
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ASA = American Society of Anesthesiologists; BMI = body mass index; CoC = ceramic-on-ceramic; CoP = 
ceramic-on-polyethylene; MoM = metal-on-metal; MoP = metal-on-polyethylene; SD = standard deviation; 
SMD = standardised mean difference; THA = total hip arthroplasty 
Values in brackets are percentages unless otherwise indicated.  
Table 1
 
* Missing data for stated number of hips: BMI (n=15,288 in unmatched cohort, and n=11,783 in matched 
cohort). 




Table 2 Indications for 350 all-cause revision procedures following primary total hip 
arthroplasty performed for hip fractures 
 
Indication for revision surgery Number of revised hips with 
indication (% of all revisions) 
Dislocation / subluxation 118 (33.7) 
Periprosthetic fracture 84 (24.0) 
Aseptic loosening 55 (15.7) 
Infection 53 (15.1) 
Malalignment 36 (10.3) 
Pain 25 (7.1) 
Implant wear 19 (5.4) 
Adverse soft tissue reaction to particulate debris 15 (4.3) 
Other 13 (3.7) 
Lysis 4 (1.1) 
Implant fracture 3 (0.9) 
Head socket mismatch 2 (0.6) 
 
One or more indications may be selected for each hip undergoing revision. 
A number of the revision indications (aseptic loosening; implant malalignment; periprosthetic 
fracture; lysis; implant fracture) can include a problem on either the femoral side or the 
acetabular side or both sides. 
 
Table 2
Table 3 Outcomes following primary total hip arthroplasty performed for hip fractures by 
surgical approach in the matched cohort 













5 year implant 









SHR = 1.15 
(0.93-1.42) 
p=0.185 
5 year implant 
survival rate free 
from dislocation or 
subluxation 







SHR = 1.28 
(0.89-1.84) 
p=0.188 
5 year implant 
survival rate free 
from periprosthetic 





















HR = 0.44 
(0.30-0.64) 
p < 0.001 




(93.7-94.5) (92.7-93.8) (94.5-95.5) (0.64-0.84) 
p < 0.001 









HR = 0.87 
(0.81-0.94) 











OR = 0.59 
(0.45-0.78) 
p < 0.001 
 
HR = hazard ratio; OR = odds ratio; SHR = sub-hazard ratio 
Numbers in brackets represent the 95% confidence intervals. 
Hazard, odds, and sub-hazard ratios below 1 represent a reduced risk of the specified 
















































Patient survival at up to 1 year following THA
Figure 2
Appendix Table Outcomes following primary total hip arthroplasty performed for hip 

















5 year implant 









SHR = 1.14 
(0.95-1.37) 
p=0.164 
5 year implant 
survival rate free 
from dislocation or 
subluxation 







SHR = 1.18 
(0.85-1.63) 
p=0.326 
5 year implant 
survival rate free 
from periprosthetic 





















HR = 0.66 
(0.49-0.88) 
p = 0.005 
Appendix









HR = 0.93 
(0.83-1.04) 
p = 0.197 









HR = 0.98 
(0.92-1.05) 











OR = 0.67 
(0.53-0.84) 
p = 0.001 
 
HR = hazard ratio; OR = odds ratio; SHR = sub-hazard ratio 
Numbers in brackets represent the 95% confidence intervals. 
Hazard, odds, and sub-hazard ratios below 1 represent a reduced risk of the specified 
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